Evidence map›Paper›PMID 38670723›Full record

ReviewRheumatic diseases clinics of North America2024

Patient Voices in Rheumatic Immune-related Adverse Events.

Kara N Corps, Oliver Terry, Maria A Lopez-Olivo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Rheumatic diseases clinics of North America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kara N CorpsDepartment of Veterinary Biosciences, The Ohio State University, College of Veterinary Medicine and OSU Comprehensive Cancer Center, 470 Veterinary Medicine Academic Building, 1900 Coffey Road, Columbus, OH 43210, USA.
Oliver TerryDepartment of Medicine and Health Sciences, McGill University, 3605 de La Montagne, Montreal, Quebec, H3G 2M1, Canada.
Maria A Lopez-OlivoDepartment of Health Services Research, MD Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Unit 1444, Houston, TX 77030, USA. Electronic address: amlopezo@mdanderson.org.

Funding

Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibitionK08CA237619 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOPEZ-OLIVO, MARIA DE LOS ANGELES · 2020 to 2024
$938k
NCI NIH HHS K08 CA237619
6 · The paper itself

Abstract

Patients with cancer considering immune checkpoint inhibitor (ICI) therapy often look for health information and peer support through online communities. The authors used social media content analysis to obtain the perspectives of patients receiving ICI treatment about immune-related adverse events (irAEs), with particular focus on rheumatological symptoms. The most reported rheumatic symptom was joint pain. Other commonly reported symptoms included muscle pain, joint stiffness, arthritis, myositis, bone pain, back pain, and tendon/ligament pain. A few users reported development of rheumatic diseases. The authors' analyses allowed for cataloging and assessment of patient and caregiver experiences with ICI therapy and rheumatic irAEs.

Indexed as

Immune Checkpoint InhibitorsNeoplasmsRheumatic DiseasesHumansSocial MediaImmune Checkpoint InhibitorsImmune checkpoint inhibitorsImmune-related adverse eventsImmunotherapyPatient perspectiveQualitative researchSocial media content analysis

Identifiers

PMID38670723
PMCPMC11058408

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.